FFL
PFE icon

Financial Freedom LLC’s Pfizer PFE Stock Holding History

Financial Freedom LLC’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,318
Closed -$121K – 313
2026
Q1 		$121K Buy
4,318
+230
+6% +$6.12K 0.06% 126
2025
Q4 		$102K Buy
4,088
+34
+0.8% +$857 0.05% 137
2025
Q3 		$103K Sell
4,054
-41
-1% -$1.01K 0.05% 135
2025
Q2 		$99.3K Buy
4,095
+43
+1% +$1K 0.05% 134
2025
Q1 		$103K Buy
4,052
+39
+1% +$1.02K 0.06% 131
2024
Q4 		$106K Sell
4,013
-167
-4% -$4.53K 0.06% 126
2024
Q3 		$121K Buy
4,180
+34
+0.8% +$992 0.06% 127
2024
Q2 		$116K Sell
4,146
-1,661
-29% -$45.7K 0.07% 127
2024
Q1 		$161K Buy
5,807
+35
+0.6% +$971 0.1% 109
2023
Q4 		$166K Sell
5,772
-752
-12% -$22.7K 0.11% 102
2023
Q3 		$216K Sell
6,524
-3
-0% -$106 0.15% 85
2023
Q2 		$239K Buy
6,527
+28
+0.4% +$1.09K 0.17% 75
2023
Q1 		$265K Buy
6,499
+203
+3% +$8.77K 0.19% 72
2022
Q4 		$323K Buy
+6,296
New +$302K 0.22% 57

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Financial Freedom LLC's PFE Position: Q2 2026 in Review

Financial Freedom LLC sold out of Pfizer (PFE) in Q2 2026, closing a stake of 4,318 shares — an estimated $121K sold.

Financial Freedom LLC first reported a position in PFE in Q4 2022 and held it in 14 quarters. The position peaked at $323K in Q4 2022. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Financial Freedom LLC reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Financial Freedom LLC sold 4,318 Pfizer shares in Q2 2026, an estimated $121K.
  • Financial Freedom LLC first reported a position in Pfizer in Q4 2022 and held it in 14 quarters.
  • Financial Freedom LLC's Pfizer position peaked at $323K in Q4 2022.
  • 2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Financial Freedom LLC's 13F filing for Q2 2026, filed 6 Aug 2026.